GKWIM
DGX icon

Gerber Kawasaki Wealth & Investment Management’s Quest Diagnostics DGX Stock Holding History

Gerber Kawasaki Wealth & Investment Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.19M Buy
5,625
+2,427
+76% +$476K 0.03% 159
2026
Q1 		$625K Buy
+3,198
New +$621K 0.02% 199
2021
Q4 		– Sell
-5
Closed -$5K – 488
2021
Q3 		$5K Buy
+5
New +$732 ﹤0.01% 756

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Gerber Kawasaki Wealth & Investment Management's DGX Position: Q2 2026 in Review

Gerber Kawasaki Wealth & Investment Management increased its Quest Diagnostics (DGX) stake by 76% in Q2 2026, buying an estimated $476K and bringing the position to 5,625 shares worth $1.19M. The position accounts for 0.03% of the portfolio, ranked #159.

Gerber Kawasaki Wealth & Investment Management first reported a position in DGX in Q3 2021 and has held it in 3 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Gerber Kawasaki Wealth & Investment Management held 5,625 shares of Quest Diagnostics worth $1.19M as of Q2 2026.
  • Gerber Kawasaki Wealth & Investment Management bought 2,427 Quest Diagnostics shares in Q2 2026, an estimated $476K.
  • Quest Diagnostics made up 0.03% of Gerber Kawasaki Wealth & Investment Management's portfolio in Q2 2026, its #159 holding.
  • Gerber Kawasaki Wealth & Investment Management first reported a position in Quest Diagnostics in Q3 2021 and has held it in 3 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Gerber Kawasaki Wealth & Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.